Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014 Mar;19(9):289-300.
Stanford RS, Nagar SP, Lin X, O'Conner R. Impact of change in inhaled corticosteroids/long-acting beta agonist combination (ICS/LABA) use on the risk of asthma exacerbations in asthma patients within a medical group. Poster presented at the 2014 AAAAI Annual Meeting; February 2014. San Diego, CA. [abstract] J Allergy Clin Immunol. 2014 Feb; 133(2):AB7.